Company / Interest Expense
Syndax Pharmaceuticals Inc Interest Expense History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$208.0K
FY2023
5-year range
$208.0K / $3.1M
FY2020-FY2023
Trend
-93.4%
vs FY2022
Sector context
#38 of 44
Health Care
What the data says
Syndax Pharmaceuticals Inc's interest expense of $208,000 is lower than 86% of companies in the Health Care sector (FY2023). Improved from $2M to $208,000 over the past 2 years.
Based on SEC 10-K filings.
$208,000 in FY2023 with a 3-year CAGR of -55.5%.
Improved from $2M to $208,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -55.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 44This company $208.0K Sector average $291.0M
▼
-99.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -55.5%, indicating a declining trend.
- In FY2023, interest expense decreased 93.4% year-over-year.
- Ranks #38 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $208.0K | -93.4% |
| FY2022 | $3.1M | +33.1% |
| FY2021 | $2.4M | +0.0% |
| FY2020 | $2.4M | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026